<?xml version="1.0" ?>
<!DOCTYPE pmc-articleset PUBLIC "-//NLM//DTD ARTICLE SET 2.0//EN" "https://dtd.nlm.nih.gov/ncbi/pmc/articleset/nlm-articleset-2.0.dtd">

<pmc-articleset><article article-type="research-article" xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:xlink="http://www.w3.org/1999/xlink">
<!--The publisher of this article does not allow downloading of the full text in XML form.-->
<front>
<journal-meta>
<journal-id journal-id-type="nlm-ta">J Physiol</journal-id>
<journal-id journal-id-type="iso-abbrev">J. Physiol. (Lond.)</journal-id>
<journal-id journal-id-type="doi">10.1111/(ISSN)1469-7793</journal-id>
<journal-id journal-id-type="publisher-id">TJP</journal-id>
<journal-id journal-id-type="hwp">jphysiol</journal-id>
<journal-title-group>
<journal-title>The Journal of Physiology</journal-title>
</journal-title-group>
<issn pub-type="ppub">0022-3751</issn>
<issn pub-type="epub">1469-7793</issn>
<publisher>
<publisher-name>John Wiley and Sons Inc.</publisher-name>
<publisher-loc>Hoboken</publisher-loc>
</publisher>
</journal-meta>
<article-meta>
<article-id pub-id-type="pmid">27198167</article-id>
<article-id pub-id-type="pmc">4983629</article-id>
<article-id pub-id-type="doi">10.1113/JP271897</article-id>
<article-id pub-id-type="publisher-id">TJP7340</article-id>
<article-categories>
<subj-group subj-group-type="article-subject-classification">
<subject>Cellular and Molecular Neuroscience</subject>
</subj-group>
<subj-group subj-group-type="article-subject-classification">
<subject>Neurological Conditions, Disorders and Treatments</subject>
</subj-group>
<subj-group subj-group-type="article-subject-classification">
<subject>Neural Circuits and Systems</subject>
</subj-group>
<subj-group subj-group-type="overline">
<subject>Symposium Related Research Paper</subject>
</subj-group>
<subj-group subj-group-type="heading">
<subject>Symposium Related Research Paper</subject>
</subj-group>
</article-categories>
<title-group>
<article-title>Cellular and circuit mechanisms underlying spinocerebellar ataxias</article-title>
<alt-title alt-title-type="left-running-head">P. Meera and others</alt-title>
<alt-title alt-title-type="right-running-head">Mechanisms underlying spinocerebellar ataxias</alt-title>
</title-group>
<contrib-group>
<contrib contrib-type="author" id="tjp7340-cr-0001">
<name>
<surname>Meera</surname>
<given-names>Pratap</given-names>
</name>
<xref ref-type="aff" rid="tjp7340-aff-0001">
<sup>1</sup>
</xref>
</contrib>
<contrib contrib-type="author" id="tjp7340-cr-0002">
<name>
<surname>Pulst</surname>
<given-names>Stefan M.</given-names>
</name>
<xref ref-type="aff" rid="tjp7340-aff-0002">
<sup>2</sup>
</xref>
</contrib>
<contrib contrib-type="author" corresp="yes" id="tjp7340-cr-0003">
<name>
<surname>Otis</surname>
<given-names>Thomas S.</given-names>
</name>
<xref ref-type="aff" rid="tjp7340-aff-0001">
<sup>1</sup>
</xref>
<xref ref-type="aff" rid="tjp7340-aff-0003">
<sup>3</sup>
</xref>
</contrib>
</contrib-group>
<aff id="tjp7340-aff-0001">
<label>
<sup>1</sup>
</label>
<named-content content-type="organisation-division">Department of Neurobiology, Geffen School of Medicine</named-content>
<institution>University of California</institution>
<named-content content-type="street">650 Charles Young Drive</named-content>
<named-content content-type="city">Los Angeles</named-content>
<named-content content-type="country-part">CA</named-content>
<named-content content-type="post-code">90095</named-content>
<country country="US">USA</country>
</aff>
<aff id="tjp7340-aff-0002">
<label>
<sup>2</sup>
</label>
<named-content content-type="organisation-division">Department of Neurology</named-content>
<institution>University of Utah</institution>
<named-content content-type="street">175 N Medical Drive E</named-content>
<named-content content-type="city">Salt Lake City</named-content>
<named-content content-type="country-part">UT</named-content>
<named-content content-type="post-code">84132</named-content>
<country country="US">USA</country>
</aff>
<aff id="tjp7340-aff-0003">
<label>
<sup>3</sup>
</label>
<named-content content-type="organisation-division">Roche Pharmaceutical Research and Early Development (pRED)</named-content>
<institution>Neuroscience, Ophthalmology and Rare Diseases (NORD)</institution>
<named-content content-type="street">Grenzacherstrasse 124</named-content>
<named-content content-type="post-code">CH‐4070</named-content>
<named-content content-type="city">Basel</named-content>
<country country="CH">Switzerland</country>
</aff>
<author-notes>
<corresp id="correspondenceTo"><label>*</label><bold>Corresponding author</bold> T. S. Otis: Neuroscience, Neuroscience, Ophthalmology and Rare Diseases, F. Hoffmann‐La Roche, Grenzacherstrasse 124, Bldg 68/Rm 403, Basel 4070, Switzerland. Email: <email>thomas_stephen.otis@roche.com</email></corresp>
</author-notes>
<pub-date pub-type="epub">
<day>12</day>
<month>6</month>
<year>2016</year>
</pub-date>
<pub-date pub-type="ppub">
<day>15</day>
<month>8</month>
<year>2016</year>
</pub-date>
<volume>594</volume>
<issue>16</issue>
<issue-id pub-id-type="doi">10.1113/tjp.2016.594.issue-16</issue-id>
<fpage>4653</fpage>
<lpage>4660</lpage>
<history>
<date date-type="received">
<day>13</day>
<month>11</month>
<year>2015</year>
</date>
<date date-type="accepted">
<day>13</day>
<month>3</month>
<year>2016</year>
</date>
</history>
<permissions>
<!--<copyright-statement content-type="issue-copyright"> Journal compilation &#x000a9; 2016 The Physiological Society <copyright-statement>-->
<copyright-statement content-type="article-copyright">© 2016 The Authors. The Journal of Physiology © 2016 The Physiological Society</copyright-statement>
</permissions>
<self-uri content-type="pdf" xlink:href="file:TJP-594-4653.pdf" xlink:type="simple"></self-uri>
<abstract>
<title>Abstract</title>
<p>Degenerative ataxias are a common form of neurodegenerative disease that affect about 20 individuals per 100,000. The autosomal dominant spinocerebellar ataxias (SCAs) are caused by a variety of protein coding mutations (single nucleotide changes, deletions and expansions) in single genes. Affected genes encode plasma membrane and intracellular ion channels, membrane receptors, protein kinases, protein phosphatases and proteins of unknown function. Although SCA‐linked genes are quite diverse they share two key features: first, they are highly, although not exclusively, expressed in cerebellar Purkinje neurons (PNs), and second, when mutated they lead ultimately to the degeneration of PNs. In this review we summarize ataxia‐related changes in PN neurophysiology that have been observed in various mouse knockout lines and in transgenic models of human SCA. We also highlight emerging evidence that altered metabotropic glutamate receptor signalling and disrupted calcium homeostasis in PNs form a common, early pathophysiological mechanism in SCAs. Together these findings indicate that aberrant calcium signalling and profound changes in PN neurophysiology precede PN cell loss and are likely to lead to cerebellar circuit dysfunction that explains behavioural signs of ataxia characteristic of the disease.</p>
</abstract>
<counts>
<page-count count="8"></page-count>
</counts>
<custom-meta-group>
<custom-meta>
<meta-name>source-schema-version-number</meta-name>
<meta-value>2.0</meta-value>
</custom-meta>
<custom-meta>
<meta-name>component-id</meta-name>
<meta-value>tjp7340</meta-value>
</custom-meta>
<custom-meta>
<meta-name>cover-date</meta-name>
<meta-value>15 August 2016</meta-value>
</custom-meta>
<custom-meta>
<meta-name>details-of-publishers-convertor</meta-name>
<meta-value>Converter:WILEY_ML3GV2_TO_NLMPMC version:4.9.4 mode:remove_FC converted:14.08.2016</meta-value>
</custom-meta>
</custom-meta-group>
</article-meta>
</front>
</article>
</pmc-articleset>